Retinal Biologics Market to Showcase Healthy Expansion at 11.1% CAGR During 2018 – 2028

Retinal Biologics Market: Extensive Prescription of Anti-VEGF Drugs in Ophthalmic Diseases Treatment to Aid Substantial Revenue Generation: Global Industry Analysis 2013 - 2017 and Opportunity Assessment 2018 - 2028

High Demand for Retinal Biologics Anticipated as Incidences of Diabetic Retinopathy Increase: FMI Survey

Retinal diseases are a significant concern among millions of people worldwide. According to the Centers for Disease Control and Prevention (CDC), around 1.8 Million people are affected with age-related macular degeneration (AMD) and 7.3 Million are at a high risk of loss of vision. Diabetic retinopathy, a disease that leads to blindness, is another prime concern among the aging and diabetic population. Thus, increasing aging and diabetic populations have been prominently contributing to the growth of the retinal biologics market. Apart from this, increase in healthcare expenditure and adoption to new technologies are also expected to drive the global retinal biologics market during the forecast period. According to the latest report published by the company, the global retinal biologics market is projected to account for over US$ 41,919 Mn, in terms of value, by 2028 end. The report further projects that the retinal biologics market is expected to grow at an average CAGR of 11.1% through 2028.

A sample of this report is available upon request @ https://www.futuremarketinsights.com/reports/sample/rep-gb-8663

Increasing Incidences of Diabetic Retinopathy among Diabetic Population to Drive Demand for Retinal Biologics

Diabetic Retinopathy (DR) is the leading cause of vision loss among adults of 20-74 years of age. It a common cause of bilateral vision loss. Changes in diet and lifestyle have led to an increase in the prevalence of DR. According to a report by the American Academy of Ophthalmology published in 2016, 93 Million people are affected by DR worldwide. Anti-VEGF and TNFα inhibitor are commonly used to treat diabetic retinopathy. Vascular endothelial growth factor (VEGF) has the potential to accelerate the process of vascular proliferation and regress DR with anti-VEGF treatment. Growing prescription of anti-VEGF has been driving the growth of the retinal biologics market. A number of manufacturers are focusing on developing drugs with anti-VEGF inhibitor, which in turn has been translating to an increase in the demand for retinal biologics.

Get more information on this report:https://www.futuremarketinsights.com/press-release/retinal-biologics-market

North America to Hold Substantial Revenue Share in the Global Retinal Biologics Market

North America is a prominent region the global retinal biologics market. Visual impairment and blindness are key concerns in North America and the North America retinal biologics market is estimated to create an incremental $ opportunity worth US$ 12,702 Mn between 2018 and 2028. Eylea and Lucentis, marketed by Regeneron and Roche in the United States, are the commonly prescribed biologics. The North America region holds a significant share among all other regions, due to the increase in the number of healthcare facilities, growth in the adoption of new and expensive drugs and easy availability of biologics.

Retinal Biologics Market: Segmental Analysis

The global retinal biologics market has been segmented on the basis of drug class, indication and distributional channel. On the basis of drug class, the retinal biologics market has been segmented into VEGF-A antagonist and TNF-α inhibitor. Based on indication, the retinal biologics market has been segmented into macular degeneration, diabetic macular edema, diabetic retinopathy, uveitis and others. In terms of revenue, the VEGF-A antagonist retinal biologics segment is expected to hold a major share during the forecast period as VEGF-A antagonist prevents angiogenesis. On the basis of distributional channel, the retinal biologics market has been segmented into institutional sales and retail sales. The institutional sales segment in retinal biologics is expected to register high revenue growth, owing to the increasing usage of biologics in hospitals and clinics for the treatment of retinal diseases.

To view TOC of this report is available upon request @ https://www.futuremarketinsights.com/askus/rep-gb-8663

Retinal Biologics Market: Companies

The report tracks some of the key companies operating in the retinal biologics market, such as Spark Therapeutics, Inc., F. Hoffmann-La Roche Ltd, Regeneron Pharmaceuticals, Inc., AbbVie Inc., Johnson & Johnson Services, Inc., and Amgen Inc.

Comments

No comments to display.

Related posts

Industrial Vacuum Cleaners Market Poised to Expand at 5.3% CAGR During 2018 – 2028

Industrial Vacuum Cleaners Market: Growth of the Manufacturing Industry to Boost Revenue: Global Industry Analysis 2013 - 2017 & Opportunity Assessment 2018 - 2028

Foot Orthotic Insoles Market: Global Industry Analysis and Forecast 2018 - 2025

The global Foot Orthotic Insoles market is valued at million US$ in 2017 and will reach million US$ by the end of 2025, growing at a CAGR of during 2018-2025.

Flexible Heaters Market to Reap Excessive Revenues by 2028

A flexible heater is a device that can be integrated to a surface that requires heating, and can be molded to the shape of the heated object.

Wireless Blood Pressure Monitors Market: Global Industry Analysis and Forecast 2019 - 2025: Stats and Reports

The global Wireless Blood Pressure Monitors market is valued at million US$ in 2017 and will reach million US$ by the end of 2025, growing at a CAGR of during 2018-2025.

Demand for Companion Diagnostics to Witness Rapid Surge During the Period 2020

Persistence Market Research has announced the addition of the “ Companion Diagnostics Market to Register Steady Expansion During 2020" report to their offering.

Compact Variable Compressor Market To Hold a High Potential for Growth by 2028

The compact variable compressor automatically varies its capacity to meet the varying cooling demands of the system.

Global Firewood Processing Machine Market to Witness Significant Revenue Growth Through 2028

Persistence Market Research has announced the addition of the “Firewood Processing Machine Market: Global Industry Analysis and Opportunity Assessment 2018- 2028" report to their offering.

Hemp Protein Market Poised to Expand at a Robust Pace Over 2016 – 2026

Hemp protein market is segmented on the basis of form, application and geography. Based upon form, hemp protein market is segmented into powdered form, and liquid form. Hemp protein in the powdered form is expected to witness high demand over the forecast period